Use PCR when you have a defined viral target and need a fast, sensitive answer. Use metagenomic next-generation sequencing (mNGS) when the cause is unknown, a mixed infection is possible, an outbreak needs broad surveillance, or the viral genome itself must be characterized. PCR searches for sequences chosen in advance. mNGS sequences detectable nucleic acids in the specimen and compares the resulting reads with reference databases, so it can reveal unexpected or novel agents without a virus-specific primer set.
Neither method is universally “more sensitive.” PCR generally wins when a known virus is present at low abundance. mNGS gains breadth but loses sensitivity when viral nucleic acid is scarce, host nucleic acid dominates, sequencing depth is limited, or bioinformatics thresholds are conservative. A common laboratory strategy is targeted PCR for routine screening and confirmation, followed by sequencing of selected positives or unexplained specimens.
As an Amazon Associate I earn from qualifying purchases.
What PCR and metagenomic sequencing actually measure
PCR, RT-PCR and qPCR are targeted tests
Polymerase chain reaction uses primers designed to bind a particular sequence. After extraction, the assay amplifies that region and detects the amplified product. A conventional PCR can show whether a target is present; real-time PCR (qPCR) monitors amplification during the reaction and can provide a cycle-threshold value related to the amount of starting template. For RNA viruses, reverse-transcription PCR (RT-PCR) first converts viral RNA into complementary DNA.
The question is deliberately narrow: “Is the sequence targeted by this assay present in this specimen?” Multiplex PCR can put several known viruses into one panel, but every target still has to be selected before testing. A virus with a substantially different genome, a new strain that disrupts primer binding, or an entirely unexpected pathogen can be missed even when it is biologically important.
#1 Best Overall
- Read Before You Buy — No Video Output: These adapters support charging and USB 2.0 data transfer, but cannot transmit video signals. Except for standard USB webcams (which use USB data only), they are not compatible with HDMI/DisplayPort cables, video-capable USB-C hubs, or docking stations with video output.
- Convert USB-A Ports to USB-C: Designed to connect USB-C earphones, cables, flash drives, card readers, and other USB-C accessories to standard USB-A ports. Plug-and-play with no drivers or software required.
- Aluminum Alloy Housing: Built with a sturdy aluminum alloy shell that aids in heat dissipation and protects against daily wear and scratches. Designed to maintain a stable and secure connection.
- Compact & Travel-Friendly: The ultra-compact design allows the adapter to stay plugged into your device without blocking adjacent ports or adding bulk, reducing wear and tear on your original USB ports.
- 12-Month Warranty: Backed by a 12-month manufacturer warranty for peace of mind. Designed to meet strict quality control standards for reliable everyday performance.
Metagenomic sequencing is broad and comparatively agnostic
mNGS extracts nucleic acids from a specimen, prepares them for sequencing and generates millions of short reads (or, on some platforms, longer reads). Software removes or down-ranks host material, compares reads with reference databases and may assemble reads into longer contigs or near-complete genomes. The workflow can support detection, discovery, subtype assignment, genome characterization and surveillance in one data set.
“Agnostic” does not mean that every virus will automatically be found. A virus must contribute enough readable nucleic acid, survive extraction and library preparation, and have sequence that can be recognized by the available database or by a de-novo assembly and downstream analysis. Highly divergent viruses, very short fragments and low-level contamination remain difficult cases.
Head-to-head comparison
| Criterion | PCR/RT-PCR/qPCR | Metagenomic sequencing | What it means in practice |
|---|---|---|---|
| Target breadth | One or a defined panel of known targets | Potentially all detectable nucleic acids in the specimen | Choose PCR for a focused question; choose mNGS when the differential diagnosis is broad. |
| Unknown-virus discovery | Not expected unless a primer happens to match | Possible through database matching, assembly or distant homology | mNGS is the better discovery tool, but a negative result does not prove that no novel virus is present. |
| Low viral load | Usually the stronger option for a known target because amplification concentrates that sequence | Can be limited by host background, extraction loss and finite read depth | A negative mNGS result needs context about biomass, depth and controls. |
| Specificity | High when primers and probe are well designed; primer contamination or cross-reactivity can still create false positives | Depends on read quality, database assignment, contamination controls and reporting thresholds | Both methods require positive and negative controls and confirmation of surprising findings. |
| Turnaround | Usually the faster workflow for a known virus | Includes extraction, library preparation, sequencing and computational analysis | Use PCR when a clinical decision cannot wait for a sequencing run. |
| Cost | Generally lower per target or panel | Usually higher because of library reagents, instrument time, computing and specialist review | Reserve mNGS for cases where its breadth or genomic information changes the decision. |
| Equipment and analysis | Thermocycler or qPCR instrument and assay-specific reagents | Sequencer, library-preparation capability, quality controls, databases and bioinformatics | mNGS needs a more complex quality-management system. |
| Genome information | Limited to the amplified region unless a separate sequencing step is added | Can provide partial to near-complete genomes, depending on coverage | Use sequencing when subtype, mutation or transmission information matters. |
| Routine throughput | Well suited to high-volume, standardized screening | Can multiplex many specimens, but interpretation remains computationally intensive | High sample volume favors PCR for routine testing and mNGS for selected batches or investigations. |
When PCR is the better first test
A known virus is suspected
If symptoms, exposure history and specimen type point to a particular virus, a validated PCR assay usually gives the most actionable answer with the least operational overhead. This is the normal starting point for clinical screening, treatment decisions and infection-control actions when the likely pathogen is already on the laboratory’s menu.
Do these 3 things before closing this tab:
1Scan for outdated or missing drivers - takes under a minute2Repair Windows errors before they cause bigger problems3Fix the driver behind crashes, sound loss and screen glitchesAn urgent result is needed
Targeted amplification avoids the sequencing run and most of the downstream classification work. A laboratory can process a defined PCR panel in a standardized batch and report a positive or negative result without waiting for broad taxonomic review.
Viral concentration is low but the target is defined
Amplification gives PCR an important analytical advantage at low abundance. mNGS must spend reads on everything extracted from the specimen, including human nucleic acid, bacteria, fungi and environmental material. In respiratory samples, a recent validation found that mNGS sensitivity increased with viral load and was constrained by high host biomass and low pathogen biomass.
Rank #2
- 5-in-1 USB-C Hub: Experience comprehensive connectivity featuring a Power Delivery input, two USB-A 2.0 ports, a USB-A 3.0 port, and an HDMI port. (Note: The USB-C power delivery input port is only for connecting an external wall charger to power your laptop and cannot power peripheral devices.)
- 90W Pass-Through Charging: Achieve optimal charging with 90W pass-through power to your laptop, supported by a total input of 100W, with the hub reserving 10W for operational efficiency. (Note: Wall charger not included.)
- Quick Data Transfers: Accelerate your productivity with rapid data transfers using a high-speed 5Gbps USB 3.0 port and two 480Mbps USB 2.0 ports.
- 4K HDMI Display: Enhance your visual experience with a hub capable of delivering 4K resolution at 30Hz in both mirror and extend modes. Please note that this hub is compatible with MacBook (macOS 12 and newer), Windows 10 and 11, ChromeOS, and laptops equipped with DP Alt Mode and Power Delivery. Note: This device is not compatible with Linux.
- What You Get: Anker USB-C Hub (5-in-1, 4K HDMI), welcome guide, 18-month warranty, and our friendly customer service.
Large-scale routine screening is required
Once targets and specimen types are stable, PCR panels are easier to standardize, validate and quality-control across high sample volumes. Multiplexing expands coverage, but it does not remove the need to decide which viruses belong in the panel.
When metagenomic sequencing adds value
The cause is unexplained after routine testing
mNGS can search beyond the organisms included in a PCR panel. It is most useful when repeated targeted tests are negative but clinical, epidemiological or imaging evidence still indicates infection, or when the differential diagnosis includes an unusual virus that the laboratory did not anticipate.
Unexpected co-infection is plausible
One specimen can contain more than one virus. A positive PCR result may explain part of the illness while a second agent remains undetected because it was not included in the panel. mNGS can reveal multiple viral sequences in the same data set, although each detection still needs clinical interpretation and, where appropriate, orthogonal confirmation.
Outbreak investigation and emerging-pathogen surveillance
Broad sequencing can identify an unfamiliar agent, compare genomes from different patients, and show whether cases are related. The Nature Reviews Microbiology literature identifies unknown or novel infection diagnosis, outbreak investigation and surveillance of emerging pathogens as important applications.
Variant or genome characterization is needed
PCR can screen for a suspected variant-defining mutation, but it does not automatically establish the full genomic context. Sequencing can determine whether mutations occur together on the same genome, identify additional changes and support phylogenetic analysis. WHO technical guidance states: “Whole Genome Sequencing, or at least complete or partial S-gene, should be performed to confirm infection with a specific variant.” It also states: “When PCR-based assays are used, confirmatory sequencing of at least a subset of viruses should be performed to be able to use these assay results as indicators of community circulation of the variants of concern.”
Rank #3
- Sleek 7-in-1 USB-C Hub: Features an HDMI port, two USB-A 3.0 ports, and a USB-C data port, each providing 5Gbps transfer speeds. It also includes a USB-C PD input port for charging up to 100W and dual SD and TF card slots, all in a compact design.
- Flawless 4K@60Hz Video with HDMI: Delivers exceptional clarity and smoothness with its 4K@60Hz HDMI port, making it ideal for high-definition presentations and entertainment. (Note: Only the HDMI port supports video projection; the USB-C port is for data transfer only.)
- Double Up on Efficiency: The two USB-A 3.0 ports and a USB-C port support a fast 5Gbps data rate, significantly boosting your transfer speeds and improving productivity.
- Fast and Reliable 85W Charging: Offers high-capacity, speedy charging for laptops up to 85W, so you spend less time tethered to an outlet and more time being productive.
- What You Get: Anker USB-C Hub (7-in-1), welcome guide, 18-month warranty, and our friendly customer service.
Is mNGS more sensitive than PCR?
There is no single sensitivity ranking that applies to every mNGS workflow. Sensitivity depends on specimen type, extraction method, viral load, host background, whether the assay enriches viral material, sequencing depth, read length, database quality, contamination filtering and the threshold used to call a virus present. PCR sensitivity also depends on primer and probe design, specimen quality, inhibition and the timing of collection.
Evidence from wastewater
In a 2026 comparison of SARS-CoV-2 methods in wastewater, targeted RT-PCR had a 68% detection likelihood and qPCR had a 65% detection likelihood. Target-agnostic approaches were less likely to detect the virus in that study. Hybrid capture improved metagenomic detection, but it remained less effective than targeted sequencing under those conditions. Wastewater contains degraded, diluted and mixed material, so these percentages should not be transferred to patient swabs or other specimens.
Evidence from respiratory nanopore sequencing
A 2026 respiratory study reported 51% sensitivity compared with PCR, with a 95% confidence interval of 45%–57%. Specificity was 99.8% (3,836 of 3,845 PCR-negative samples). Sensitivity varied from 19% to 85% by pathogen, and the reported multiplexed sequencing cost was £112 per sample. Those results describe that study’s specimen processing, platform, pathogen mix and analysis pipeline; they are not a universal performance specification for nanopore mNGS.
Evidence from a different validated workflow
A 2024 Nature Communications study comparing an mNGS respiratory workflow with an RT-PCR respiratory viral panel reported 93.6% sensitivity, 93.8% specificity and 93.7% accuracy across 191 samples. The substantially higher figures than the respiratory nanopore study illustrate why assay-specific validation matters: “mNGS” describes a class of workflows, not one standardized test.
How long does viral mNGS take, and what does it cost?
mNGS turnaround includes more than instrument run time. The laboratory must extract nucleic acid, prepare a library, sequence it, perform quality control, classify reads, assess contamination and have a qualified person review the result. A 2021 systematic review reported a median sample-to-result time of 29 hours, with a range of 4–144 hours, and consumable costs of $130–$685 per sample. The review found substantial heterogeneity by specimen type and workflow, so these figures are planning ranges rather than a universal price or promise.
Rank #4
- Dual Converters, Infinite Potential：Includes 2× USB C male to USB A female adapters and 2× USB A male to USB C female adapters. Perfect for a wide range of uses—tablets with Bluetooth keyboards, expand USB ports on macbook, and more. Two different converters for all your daily needs
- Next-Level 10Gbps & 3A Charging: No more slow 480Mbps, this usb to usb c adapter has a transfer speed of up to 10Gbps, allowing you to do more transferring in less time. This usb adapter fits both USB A and USB C charger, supporting up to 3A fast charging
- Upgraded Exquisite Craftsmanship: With an aluminum alloy housing and metal connector, the usbc to usb adapter is extremely durable and sturdy. Rigorously tested to withstand more than 10,000 times of plugging and unplugging, ensuring long-lasting performance
- Broad Compatible: The usb c to usb adapter widely supports all USB C/ USB A devices like laptops, tablets, cellphones, car chargers, and phone chargers. Such as compatible with MacBook Pro/Air 2023/2022, Thunderbolt 4/3 Devices,Apple MagSafe Watch 9/8/7/SE/Ultra, iPad Pro 2022/2021, Samsung Galaxy S23/S20/S10, and iPhone 17/16/15 Pro. Plug and play
- Please Note: To reach 10Gbps speed, keep the cable under 3.3 ft. For USB A Male to USB C adapters, try flipping the USB C connector. USB C Male to USB A adapters support bidirectional 10Gbps transfer within 3.3 ft
PCR is generally less expensive per result because amplification uses assay-specific reagents and avoids broad sequencing and computational analysis. The actual price depends on whether the laboratory runs a single target or a multiplex panel, the number of samples in a batch, labor, controls and reporting requirements. A laboratory should compare the full cost of an mNGS result—including failed libraries, repeat runs, storage and specialist interpretation—with the cost of the targeted tests it would otherwise order.
What a PCR workflow looks like
- Define the question and specimen. Select a validated assay for the suspected virus and the specimen type actually collected. Check whether the assay detects RNA or DNA and whether reverse transcription is required.
- Extract nucleic acid. Use the validated extraction method and include an extraction control to detect loss or inhibition.
- Amplify and detect. Run the target primers and probes with positive, negative and internal controls. For qPCR, interpret the cycle-threshold result according to the laboratory’s validated cutoff rather than applying a cutoff from another assay.
- Review validity. A failed internal control, unusual amplification curve or contamination in a negative control invalidates the relevant result and may require repeat extraction or testing.
- Report within scope. State the target detected, specimen and assay limitations. A negative result means the target was not detected under the conditions of that assay; it does not exclude every virus.
What an mNGS workflow requires
- Plan specimen handling. Preserve the specimen in a way compatible with viral nucleic-acid recovery and record collection time, transport and freeze–thaw history.
- Extract and prepare nucleic acid. The laboratory may use host depletion, nuclease treatment or targeted enrichment, but each intervention can change which organisms are recoverable. RNA-virus workflows add reverse transcription before library construction.
- Build and sequence libraries. Add indexes and controls, then sequence to the validated depth. More reads can improve detection of low-abundance virus, but cannot recover nucleic acid lost during collection or extraction.
- Perform quality control. Examine read count, quality scores, duplicate levels, host-read proportion, negative controls and process controls. A virus appearing mainly in a control or at a level consistent with laboratory background should not be reported as a clinical infection without investigation.
- Classify and assemble reads. Match reads to current reference databases, inspect coverage across the genome and use de-novo assembly or protein-level searches when a close reference is unavailable.
- Interpret in clinical context. Distinguish a high-coverage, genome-spanning signal from a few reads that could reflect reagent or environmental contamination. Consider whether the detected virus fits the specimen, symptoms and epidemiology.
- Confirm important findings. Confirm an unexpected, novel or high-consequence result with an independent PCR, a second extraction, another specimen or a reference laboratory method when feasible.
Why host background and contamination matter
Host background can dilute viral signal
Respiratory, blood and tissue specimens can contain enormous quantities of human nucleic acid relative to viral material. If most sequenced reads are host-derived, only a small fraction remains available for viral detection. Host depletion or capture enrichment can improve the fraction of viral reads, but it adds steps, cost and potential bias.
Contamination can look like a real virus
Low-level viral reads may come from extraction reagents, laboratory surfaces, index misassignment or carryover from a high-positive sample. mNGS therefore needs extraction blanks, library controls, batch comparisons and explicit reporting thresholds. PCR also requires contamination control, especially when amplified products are handled near pre-amplification areas, but its defined target and probe signal often make interpretation more straightforward.
Database and threshold choices change the answer
A read cannot be classified as a virus that is absent from the reference database unless a more distant match or an assembled sequence reveals it. Conversely, permissive thresholds may report spurious low-complexity or conserved sequences. Laboratories should document database versions, minimum read or coverage requirements, host-subtraction rules, contamination handling and when confirmatory testing is mandatory.
Crashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minutePC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11Can mNGS find viruses that PCR misses?
Yes, in several situations. mNGS can detect an agent that was not included in a PCR panel, a mixed infection hidden behind the first positive result, or a strain whose mutations prevent primer binding. It can also generate sequence information that a short PCR amplicon cannot provide.
Best Value
- 5-in-1 Connectivity: Equipped with a 4K HDMI port, a 5 Gbps USB-C data port, two 5 Gbps USB-A ports, and a USB C 100W PD-IN port. Note: The USB C 100W PD-IN port supports only charging and does not support data transfer devices such as headphones or speakers.
- Powerful Pass-Through Charging: Supports up to 85W pass-through charging so you can power up your laptop while you use the hub. Note: Pass-through charging requires a charger (not included). Note: To achieve full power for iPad, we recommend using a 45W wall charger.
- Transfer Files in Seconds: Move files to and from your laptop at speeds of up to 5 Gbps via the USB-C and USB-A data ports. Note: The USB C 5Gbps Data port does not support video output.
- HD Display: Connect to the HDMI port to stream or mirror content to an external monitor in resolutions of up to 4K@30Hz. Note: The USB-C ports do not support video output.
- What You Get: Anker 332 USB-C Hub (5-in-1), welcome guide, our worry-free 18-month warranty, and friendly customer service.
That advantage is conditional. If the virus is present at very low abundance, if host nucleic acid overwhelms the library, if the genome is too divergent for reliable classification, or if the specimen was collected after viral clearance, mNGS may produce no reportable signal even though a well-designed targeted PCR would detect the virus. A negative mNGS result should therefore be interpreted alongside viral load expectations, specimen timing, read depth, controls and an appropriate targeted assay.
Choosing a method by the decision you need to make
| Situation | Preferred starting approach | Reason |
|---|---|---|
| Known virus, urgent clinical decision | Targeted PCR or RT-PCR | Fast, focused detection with strong performance for the intended target. |
| Routine screening for a stable list of viruses | Validated multiplex PCR | Standardized throughput and predictable interpretation. |
| Persistent illness with negative targeted tests | mNGS, often alongside repeat or expanded PCR | Broader search for unexpected or novel agents. |
| Possible co-infection | mNGS or an expanded multiplex panel | Tests whether additional agents are present beyond the initial target. |
| Variant confirmation or transmission analysis | PCR screening followed by partial- or whole-genome sequencing | Combines rapid case finding with genomic resolution. |
| Outbreak or emerging-pathogen investigation | mNGS with confirmatory targeted assays | Supports discovery and comparison of agents before a complete PCR panel exists. |
| Very low biomass or heavy host background | Validated targeted PCR first; interpret mNGS cautiously | Amplification may outperform untargeted read allocation in this setting. |
A practical combined strategy for laboratories
Screen broadly enough to avoid blind spots
Use a validated PCR panel for the viruses that are common, actionable or required for infection control. Define in advance which results trigger sequencing and which specimens go directly to a reference laboratory.
Sequence a purposeful subset
Sequence representative PCR-positive specimens for variant surveillance, unusual clinical presentations, reinfections, suspected transmission links or changes in assay performance. Sampling should be designed so that sequencing results can support population-level conclusions rather than only isolated case descriptions.
Free tools Windows power users keep installed
One-click scans. No signup required.
Escalate unexplained cases
When routine tests do not explain a serious illness, send an appropriately collected specimen for mNGS with complete clinical metadata and a plan for confirmatory testing. Include a second specimen or targeted assays when the result could alter treatment, isolation or public-health action.
Keep methods connected
Use PCR to confirm an mNGS signal when a suitable target becomes available, and use sequencing to investigate unusual PCR results, suspected primer mismatch or changes in the circulating virus. This two-way confirmation reduces the risk of treating either a single read or a single primer set as definitive evidence.
Common mistakes and how to avoid them
- Calling mNGS “unbiased.” Extraction chemistry, host depletion, enrichment, platform bias and databases all shape what can be seen. Describe the workflow rather than promising universal detection.
- Comparing sensitivity figures from different studies as if they were interchangeable. Keep the specimen, platform, pathogen mix, comparator and positivity definition attached to every percentage.
- Using a negative PCR to exclude every virus. It excludes the assay’s intended targets under its validated conditions, not pathogens outside the panel.
- Using a few mNGS reads as proof of disease. Check coverage, read quality, controls, contamination background and clinical fit, then confirm important findings.
- Assuming a complete genome is guaranteed. mNGS may produce only short fragments or a partial genome when abundance or coverage is insufficient.
- Ignoring specimen timing. A sample collected too early, too late or after treatment can reduce either method’s chance of detection.
- Reporting a variant from a screening mutation alone. Confirm the genomic context by partial- or whole-genome sequencing when the result will be used to identify a specific variant or infer community circulation.
What published performance numbers really mean
Performance estimates are properties of a complete workflow, not labels attached to the words “PCR” or “mNGS.” The comparator test, specimen selection, prevalence, extraction method, sequencing platform, enrichment, bioinformatics pipeline and positivity threshold can all change sensitivity, specificity and turnaround time.
The 2021 systematic review found pooled estimates varied by specimen type and emphasized methodological heterogeneity and limitations. The respiratory studies from 2024 and 2026 likewise produced very different results because they evaluated different workflows. Use published numbers to judge whether a particular validated assay fits your intended use; do not copy one study’s sensitivity into a procurement specification for another laboratory.
The Tool Desk
Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →Bottom line for clinicians, public-health teams and laboratory managers
PCR remains the practical first-line test for a known virus, low viral load, urgent decisions and high-volume screening. mNGS earns its additional cost and complexity when the pathogen is unknown, co-infection or a novel agent is plausible, an outbreak requires broad surveillance, or genomic characterization is the objective. The strongest program uses both: targeted PCR for dependable case finding, and carefully controlled sequencing for discovery, confirmation and genome-level context.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
